Nearly double the weight loss. Almost opposite side effect profiles. A side-by-side comparison using 8,664 real patient posts from Reddit and published clinical trial data. Not medical advice — evidence to inform your conversation with your doctor.
Clinical trial results at the highest studied doses. No head-to-head trial exists — these are cross-trial comparisons.
The weight loss gap here is the largest between any two GLP-1 drugs. But these were different trials with different populations — TRIUMPH-4 enrolled patients with obesity plus knee osteoarthritis (mean BMI 40.4), while STEP 1 enrolled general obesity (mean BMI 37.9). Retatrutide’s triple-agonist mechanism (GLP-1 + GIP + glucagon) provides fundamentally more metabolic activity than semaglutide’s single GLP-1 action. This is the biggest mechanistic difference between any two drugs in the GLP-1 class.
Percentage of Reddit posts for each drug mentioning each side effect, with raw post counts shown. Based on 3,580 retatrutide and 5,084 semaglutide posts.
| Side Effect | Retatrutide | Semaglutide | Signal |
|---|---|---|---|
| Nausea | 14.2%509 posts | 21.2%1,076 posts1.6× | Sema-Elevated Semaglutide has the highest nausea rate of all three GLP-1 drugs. 1,076 posts — the single largest side effect signal in the entire dataset. |
| Fatigue | 12.6%450 posts | 9.8%497 posts | Similar rates. Sema fatigue (9.8%) near-perfectly matches the Wegovy FDA label (11%). |
| Heart Rate Increase | 7.2%257 posts4.2× | 1.8%91 posts | Reta-Specific Appears at first injection, not dose-dependent. Likely binary — you either get it or you don’t. |
| Insomnia | 6.4%230 posts3.4× | 2.1%105 posts | Reta-Specific 4.5× more common in first 4 weeks. Usually self-resolving. Morning injections help. |
| Diarrhea | 5.9%210 posts | 6.6%335 posts | Sema modestly higher. |
| Constipation | 3.7%132 posts | 6.3%322 posts2.2× | Sema-Elevated 322 posts. Semaglutide has the highest constipation rate across all three drugs. |
| Skin Sensitivity | 5.6%199 posts6.1× | 1.1%55 posts | Reta-Specific Dose-dependent: 3% at 1mg → 25% at 12mg. Confirmed by Phase 3 at 20.9%. |
| Acid Reflux | 3.9%140 posts | 4.5%229 posts | Sema slightly elevated. |
| Vomiting | 0.9%31 posts | 3.0%150 posts3.3× | Sema-Elevated Both drugs massively underreported vs trials (sema trial: 24.8%). |
| Hair Loss | 1.3%47 posts | 3.1%159 posts | Sema 2× reta. Telogen effluvium from rapid weight loss, months 3–6. |
| Low Libido | 1.5%54 posts3.3× | 0.6%28 posts | Reta-Specific Not measured in any clinical trial. Reddit-only data point. |
These drugs have almost opposite side effect profiles. Semaglutide dominates in GI side effects — nausea (1,076 posts, 1.5× reta), constipation (322 posts, 1.7×), and vomiting (150 posts, 3.4×). Retatrutide dominates in non-GI side effects — heart rate (257 posts, 4.0×), insomnia (230 posts, 3.1×), skin sensitivity (199 posts, 5.1×), and low libido (54 posts, 2.7×). If you’re sensitive to GI issues, retatrutide may be more tolerable. If you’re sensitive to sleep or cardiovascular disruption, semaglutide may be easier.
Published trial results compared to what 8,664 Reddit users reported. Arrows show whether Reddit under- or over-counts relative to trials.
| Side Effect | Reta Trial | Reta Reddit | Sema Trial | Sema Reddit | Pattern |
|---|---|---|---|---|---|
| Nausea | 43% | 14.2%509 | 43.9% | 21.2%1076 | ↓ Undercounted |
| Vomiting | 21% | 0.9%31 | 24.8% | 3.0%150 | ↓↓ Heavily under |
| Diarrhea | 15% | 5.9%210 | 29.7% | 6.6%335 | ↓ Undercounted |
| Constipation | 12% | 3.7%132 | 24.2% | 6.3%322 | ↓ Undercounted |
| Skin Sensitivity | 20.9% | 5.6%199 | N/A | 1.1%55 | ↓ Undercounted |
| Fatigue | 7–10% | 12.6%450 | 11% | 9.8%497 | → Sema aligned |
| Insomnia | Not captured | 6.4%230 | Not captured | 2.1%105 | ★ New signal |
| Low Libido | Not measured | 1.5%54 | Not measured | 0.6%28 | ★ New signal |
Reddit systematically undercounts acute GI symptoms (nausea, vomiting, diarrhea) because people don’t open Reddit mid-episode. Semaglutide’s fatigue rate is the single best Reddit-to-trial alignment in the dataset — 9.8% vs the Wegovy label’s 11%. This gives us confidence that when Reddit and trial data measure the same quality-of-life effect, they converge. The signals Reddit captures that trials don’t — insomnia, low libido, craving reduction — are genuinely new information.
Side effects and patterns invisible to clinical research by design.
When Reddit data and clinical trials measure the same thing, the numbers converge. Semaglutide fatigue on Reddit (9.8%) near-perfectly matches the Wegovy FDA label (11%). Retatrutide skin sensitivity on Reddit (5.6%) aligned with Phase 2 trial data (7%), and Phase 3 TRIUMPH-4 later confirmed the dose-dependent pattern at 20.9% at 12mg. This overlap gives us confidence in the signals Reddit captures that trials don’t measure.
Of all side effect reports, what percentage were rated mild, moderate, or severe.
Semaglutide has the worst severity profile of all three GLP-1 drugs — 30% of 4,144 reports rated severe, vs just 22% for retatrutide. Semaglutide also has the lowest mild rate (27% vs 37%). This likely reflects semaglutide’s intense GI burden: nausea and vomiting are inherently more disabling than retatrutide’s characteristic side effects (insomnia, skin sensitivity), which are uncomfortable but less acutely debilitating.
Positive effects reported beyond weight loss, with raw post counts. Benefits are underreported — people post about problems more than wins.
| Benefit | Retatrutide | Semaglutide | Signal |
|---|---|---|---|
| Food Noise Eliminated | 23.8%853 posts | 17.3%879 posts | Sema has more raw mentions (879 vs 853) due to larger user base. Reta has higher rate per user. Both strongly reported. |
| Energy Increased | 10.0%357 posts | 5.0%253 posts | Reta Leads Reta users report energy gains at 2.0× the rate of sema users. |
| Blood Pressure Normalized | 2.5%90 posts | 4.9%250 posts | Sema leads. TRIUMPH-4 showed −14mmHg systolic on reta 12mg. |
| Inflammation Reduced | 4.2%152 posts | 2.8%141 posts | Similar raw counts. Reta has higher rate per user. |
| Mental Clarity | 3.9%139 posts | 3.1%158 posts | Similar rates in the updated dataset. |
| Reduced Alcohol Cravings | 3.9%139 posts | 2.9%148 posts | Uniform across all drugs — mechanism-level GLP-1 effect on nucleus accumbens. |
Retatrutide has the stronger benefit profile per user across food noise (23.8% vs 17.3%) and energy (10.0% vs 5.0%). Semaglutide leads in blood pressure normalization (4.9% vs 2.5%). Both drugs show similar rates for inflammation, mental clarity, and alcohol craving reduction. Retatrutide’s additional GIP and glucagon activity appears to provide more aggressive appetite suppression, while semaglutide’s benefit profile is more balanced.
The SELECT trial (n=17,604) showed semaglutide reduced major adverse cardiovascular events by 20% in people with existing cardiovascular disease but without diabetes. No other GLP-1 drug has this evidence. This is not captured in the Reddit benefit data above, but it’s the single strongest clinical argument for semaglutide — particularly for patients with a history of heart disease. Retatrutide has no cardiovascular outcomes data yet.
What happens when people switch — and why the flow is overwhelmingly one-directional.
The switch ratio is 18:1 in favor of sema→reta. Nobody switches back. This is even more one-directional than the tirz→reta flow (306 switches, 8.5:1 ratio). The most common pattern is sema→tirz (535 people) and then tirz→reta (565 people) — a clear escalation path through the GLP-1 class as people seek stronger results. For a detailed look at what the sema-to-reta transition actually looks like, see our switching to retatrutide analysis.
Based on the data — not a recommendation. Always discuss with your healthcare provider.
Search all 14,252 posts across retatrutide, tirzepatide, and semaglutide.
22-page analysis — side effects, remedies, benefits, women’s health, clinical trial comparisons, and recommendations by drug.